| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000235398.4 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001390805 |
Resistant |
| ENSG00000235398.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021073582 |
Resistant |
| ENSG00000235398.4 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.003259912 |
Resistant |
